Our Science – Palena Website
Claudia M. Palena, Ph.D.
Selected Publications |
 |
| 1)
Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang K, Ferrone S, Gameiro SR. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Int. J. Cancer. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton DH, Huang B, Tucker JA, Tsang KY, Schlom J, Palena C. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res. 18: 3868-79, 2012. [Journal] |
|
| 3)
Hamilton DH, Litzinger MT, Fernando RI, Huang B, Palena C. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas. Semin. Oncol. 39: 358-66, 2012. [Journal] |
|
| 4)
Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 8: 713-22, 2012. [Journal] |
|
| 5)
Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 71: 5296-306, 2011. [Journal] |
|
| 6)
Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, Schlom J. Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp. Biol. Med. (Maywood). 236: 537-45, 2011. [Journal] |
|
| 7)
Litzinger MT, Foon KA, Tsang K, Schlom J, Palena C. Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. Leuk Res. 34: 1351-7, 2010. [Journal] |
|
| 8)
Cereda V, Poole D, Palena C, Das S, Bera T, Remondo C, Gulley J, Arlen P, Yokokawa J, Pastan I, Schlom J, Tsang K. New gene expressedin prostate (NGEP): a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother. 59: 63-71, 2010. [Journal] |
|
| 9)
Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, Palena C. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J. Clin. Invest. 120: 533-44, 2010. [Journal] |
|
| 10)
Palena C, Schlom J. Vaccines against human carcinomas: strategies to improve antitumor immune responses. J. Biomed. Biotechnol. 2010: 380697, 2010. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/26/2013.
